EUVIMEDEUVIMED entdecken
Crossref

O‐glycan structures in apo(a) subunit of human lipoprotein(a) suppresses the pro‐angiogenic activity of galectin‐1 on human umbilical vein endothelial cells

Vasantha Kalaivani iD, Mahesh S Krishna, Asokan Aneesh Kumar, Gopika Satheesh, Abdul Jaleel

The FASEB Journal · 2023

DOI: 10.1096/fj.202201001rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2023. Verfasst von Vasantha Kalaivani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Biology Laboratory, Division of Cardiovascular Diseases and Diabetes Biology, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Ind…. Hauptthemen laut MEDLINE: Galectin 1, Lipoprotein(a). Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Science and Engineering Research Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Apolipoprotein(a) [apo(a)] is a highly polymorphic O‐glycoprotein circulating in human plasma as lipoprotein(a) [Lp(a)]. The O‐glycan structures of apo(a) subunit of Lp(a) serve as strong ligands of galectin‐1, an O‐glycan binding pro‐angiogenic lectin abundantly expressed in placental vascular tissues. But the pathophysiological significance of apo(a)‐galectin‐1 binding is not yet been revealed. Carbohydrate‐dependent binding of galectin‐1 to another O‐glycoprotein, neuropilin‐1 (NRP‐1) on endothelial cells activates vascular endothelial growth factor receptor 2 (VEGFR2) and mitogen‐activated protein kinase (MAPK) signaling. Using apo(a), isolated from human plasma, we demonstrated the potential of the O‐glycan structures of apo(a) in Lp(a) to inhibit angiogenic properties such as proliferation, migration, and tube‐formation in human umbilical vein endothelial cells (HUVECs) as well as neovascularization in chick chorioallantoic membrane. Further, in vitro protein‐protein interaction studies have confirmed apo(a) as a superior ligand to NRP‐1 for galectin‐1 binding. We also demonstrated that the protein levels of galectin‐1, NRP‐1, VEGFR2, and downstream proteins in MAPK signaling were reduced in HUVECs in the presence of apo(a) with intact O‐glycan structures compared to that of de‐O‐glycosylated apo(a). In conclusion, our study shows that apo(a)‐linked O‐glycans prevent the binding of galectin‐1 to NRP‐1 leading to the inhibition of galectin‐1/neuropilin‐1/VEGFR2/MAPK‐mediated angiogenic signaling pathway in endothelial cells. As higher plasma Lp(a) level in women is an independent risk factor for pre‐eclamsia, a pregnancy‐associated vascular complication, we propose that apo(a) O‐glycans‐mediated inhibition of the pro‐angiogenic activity of galectin‐1 may be one of the underlying molecular mechanism of pathogenesis of Lp(a) in pre‐eclampsia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Galectin 1Lipoprotein(a)FemaleHumansApoprotein(a)Human Umbilical Vein Endothelial CellsLigandsNeuropilin-1PolysaccharidesVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2

Stichwörter der Autor:innen

O-glycanangiogenesisapo(a)galectin-1lipoprotein(a)neuropilin-1

Substanzen

Apoprotein(a)Galectin 1LigandsLipoprotein(a)Neuropilin-1PolysaccharidesVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2

Autor:innen und Institutionen

  • Diabetes Biology Laboratory, Division of Cardiovascular Diseases and Diabetes Biology, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India.

ORCID-Profile: Vasantha Kalaivani

Förderung

  • Science and Engineering Research Board

Zitieren

APA

Kalaivani, V., Krishna, M. S., Kumar, A. A., Satheesh, G., & Jaleel, A. (2023). O‐glycan structures in apo(a) subunit of human lipoprotein(a) suppresses the pro‐angiogenic activity of galectin‐1 on human umbilical vein endothelial cells. The FASEB Journal. https://doi.org/10.1096/fj.202201001rr

Vancouver

Kalaivani V, Krishna MS, Kumar AA, Satheesh G, Jaleel A. O‐glycan structures in apo(a) subunit of human lipoprotein(a) suppresses the pro‐angiogenic activity of galectin‐1 on human umbilical vein endothelial cells. The FASEB Journal. 2023. doi:10.1096/fj.202201001rr

BibTeX
@article{Kalaivani2023,
  author = {Kalaivani, Vasantha and Krishna, Mahesh S and Kumar, Asokan Aneesh and Satheesh, Gopika and Jaleel, Abdul},
  title = {O‐glycan structures in apo(a) subunit of human lipoprotein(a) suppresses the pro‐angiogenic activity of galectin‐1 on human umbilical vein endothelial cells},
  journal = {The FASEB Journal},
  year = {2023},
  doi = {10.1096/fj.202201001rr}
}
Kostenlos starten →